Yael David
Dr. Yael David received her B.S. in Biology from SUNY Stony Brook, as a Summa Cum Laude where she was awarded the Howard Hughes Medical Institute research fellowship to perform research in molecular neurobiology. Yael subsequently moved to the Weizmann Institute of Science in Israel, where was trained as a biochemist and cell biologist, applying her knowledge to study the mechanism and regulation of polyubiquitination. Realizing the power of interdisciplinary research, she moved to the Chemistry Department at Princeton University where she combined her experience with Prof. Tom Muir’s expertise in peptide chemistry to develop novel tools towards the mechanistic investigation of histone post-translational modifications including their site-specific manipulation in live cells. This methodology opened the door to performing research with chemical precision at a biochemical resolution and in a physiological context. In 2016, Yael brought her powerful program to the Chemical Biology Program at Memorial Sloan Kettering Cancer Center. In the past 5 years, the David lab has performed highly innovative and interdisciplinary research driven by outstanding questions in the Epigenetics field. They developed key chemical tools that were applied, for example, to identify a new class of histone modifications that directly links metabolism and cell fate. Yael’s efforts thus far were recognized nationally and internationally as the ACS “future of biochemistry”, “rising start in chemical protein synthesis”, the Pershing Square Sohn Cancer Alliance award, the Parker Institute for Cancer Immunotherapy Career Award and the NIH/NIGMS outstanding young investigators award (MIRA), among others.
Abstracts this author is presenting: